NLRP3 and leukemia: In this study, in primary AML leukemia cells, LPS or LPS+ATP induced NLRP3 inflammasome activation and the activation of NLRP3 inflammasome promoted proliferation, inhibited apoptosis and increased drug-resistance of primary leukemia cells.